Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bult

Showing results (121-130 of 134) with videos related to

Pageof 14
Sort By:
Journal of Chromatography. B, Biomedical Sciences and Applications|August 1, 1998
Analysis of Ecteinascidin 743, a new potent marine-derived anticancer drug, in human plasma by high-performance liquid chromatography in combination with solid-phase extractionH Rosing, M J Hillebrand, J M Jimeno, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 4, 2000
Reduction of Cys36-Cys42 and Cys64-Cys74 disulfide bonds in recombinant human granulocyte colony stimulating factorJ Léon, E Reubsaet, J H Beijnen, et al.
International Journal of Pharmaceutics|November 14, 2002
Pharmaceutical development of a parenteral lyophilized formulation of the antimetastatic ruthenium complex NAMI-AM Bouma, B Nuijen, G Sava, et al.
Behavioural Brain Research|February 15, 2011
Predictive validity of a non-induced mouse model of compulsive-like behaviorD M Greene-Schloesser, E A Van der Zee, D K Sheppard, et al.
Journal of Mass Spectrometry : JMS|December 3, 1998
Quantitative determination of Ecteinascidin 743 in human plasma by miniaturized high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometryH Rosing, M J Hillebrand, J M Jimeno, et al.
PDA Journal of Pharmaceutical Science and Technology|August 6, 2000
Pharmaceutical development of a parenteral lyophilized formulation of the novel antitumor agent aplidineB Nuijen, M Bouma, R E Henrar, et al.
PDA Journal of Pharmaceutical Science and Technology|March 1, 1997
Pharmaceutical development of a parenteral formulation of the investigational anticancer drug clanfenurJ D Jonkman-de Vries, B J Van den Bemt, W W ten Bokkel-Huinink, et al.
European Journal of Cancer (Oxford, England : 1990)|September 17, 2025
Non-inferior outcome of abbreviated R-CHOP in patients with stage I primary testicular lymphomaDiana Al-Sarayfi, Johanna A A Bult, Ruben A L de Groen, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|December 1, 1996
A putative poststreptococcal case of OCD with chronic tic disorder, not otherwise specifiedD M Tucker, J F Leckman, L Scahill, et al.
Drug Development and Industrial Pharmacy|November 11, 2003
Pharmaceutical development of a parenteral lyophilized formulation of the investigational polymer-conjugated platinum anticancer agent AP 5280M Bouma, B Nuijen, R Harms, et al.
Pageof 14

Showing results (121-130 of 134) with videos related to

Sort By:
Pageof 14
Journal of Chromatography. B, Biomedical Sciences and Applications|August 1, 1998
Analysis of Ecteinascidin 743, a new potent marine-derived anticancer drug, in human plasma by high-performance liquid chromatography in combination with solid-phase extractionH Rosing, M J Hillebrand, J M Jimeno, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 4, 2000
Reduction of Cys36-Cys42 and Cys64-Cys74 disulfide bonds in recombinant human granulocyte colony stimulating factorJ Léon, E Reubsaet, J H Beijnen, et al.
International Journal of Pharmaceutics|November 14, 2002
Pharmaceutical development of a parenteral lyophilized formulation of the antimetastatic ruthenium complex NAMI-AM Bouma, B Nuijen, G Sava, et al.
Behavioural Brain Research|February 15, 2011
Predictive validity of a non-induced mouse model of compulsive-like behaviorD M Greene-Schloesser, E A Van der Zee, D K Sheppard, et al.
Journal of Mass Spectrometry : JMS|December 3, 1998
Quantitative determination of Ecteinascidin 743 in human plasma by miniaturized high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometryH Rosing, M J Hillebrand, J M Jimeno, et al.
PDA Journal of Pharmaceutical Science and Technology|August 6, 2000
Pharmaceutical development of a parenteral lyophilized formulation of the novel antitumor agent aplidineB Nuijen, M Bouma, R E Henrar, et al.
PDA Journal of Pharmaceutical Science and Technology|March 1, 1997
Pharmaceutical development of a parenteral formulation of the investigational anticancer drug clanfenurJ D Jonkman-de Vries, B J Van den Bemt, W W ten Bokkel-Huinink, et al.
European Journal of Cancer (Oxford, England : 1990)|September 17, 2025
Non-inferior outcome of abbreviated R-CHOP in patients with stage I primary testicular lymphomaDiana Al-Sarayfi, Johanna A A Bult, Ruben A L de Groen, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|December 1, 1996
A putative poststreptococcal case of OCD with chronic tic disorder, not otherwise specifiedD M Tucker, J F Leckman, L Scahill, et al.
Drug Development and Industrial Pharmacy|November 11, 2003
Pharmaceutical development of a parenteral lyophilized formulation of the investigational polymer-conjugated platinum anticancer agent AP 5280M Bouma, B Nuijen, R Harms, et al.
Pageof 14